On November 13, 2025, the Court of Chancery of the State of Delaware appointed Entwistle & Cappucci LLP (“E&C” or the “Firm”) as interim Lead Counsel in an action on behalf of former minority owners of Class A common stock of Paramount Global (“Paramount” or the “Company”) arising from breaches of fiduciary…

On September 2, 2025, the United States District Court for the Southern District of Florida appointed Entwistle & Cappucci LLP (“E&C” or the “Firm) as Co-Lead Counsel in the securities class action against KnowBe4, Inc. (“KnowBe4” or the “Company”) and related defendants. The case is brought on behalf of all persons or…

On June 23, 2025, the United States District Court for the District of Delaware appointed Entwistle & Cappucci LLP as Lead Counsel in the securities action against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) and related defendants. The case is brought on behalf of all persons or entities that: (a) sold…

Entwistle & Cappucci LLP today announced that it filed a First Amended Class Action Complaint (“Complaint”) against KnowBe4, Inc. (“KnowBe4”), certain of KnowBe4’s directors, KKR & Co. Inc., Elephant Partners, Vista Equity Partners Management, LLC (“Vista”) and certain of their affiliates (collectively, “Defendants”) on behalf of a class (“Class”) consisting of all…

Entwistle & Cappucci LLP today announced that its ongoing investigation has led to the filing of a class action (“Action”) against KnowBe4, Inc. (“KnowBe4”), certain of KnowBe4’s directors, KKR & Co. Inc., Elephant Partners, Vista Equity Partners Management, LLC (“Vista”) and certain of their affiliates (collectively, “Defendants”) on behalf of a class…

Entwistle & Cappucci LLP (“Entwistle & Cappucci”) today announced that its ongoing investigation has led to the filing of a class action (the “Action”) against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”), Bain Capital Investors, LLC (“Bain”) and Pfizer, Inc. (“Pfizer”) on behalf of a class (the “Class”) consisting of all…

Entwistle & Cappucci LLP (“Entwistle & Cappucci”) is investigating potential federal securities law violations on behalf of its clients and other former holders of Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) common stock. Cerevel was a publicly traded biopharmaceutical company that was acquired by AbbVie, Inc. in August 2024….

On March 20, 2025, the United States District Court for the Middle District of Tennessee appointed Entwistle & Cappucci LLP as Co-Lead Counsel in the securities class action against Revance Therapeutics, Inc. (“Revance” or the “Company”) and related defendants (collectively, “Defendants”). In August 2024, Revance and skincare product company Crown Laboratories, Inc….

On March 7, 2025, the United States District Court for the District of Delaware appointed Entwistle & Cappucci LLP as Lead Counsel in the securities class action against Capri Holdings Limited (“Capri”), Tapestry, Inc. (“Tapestry”) and related defendants (collectively, “Defendants”). The case is brought on behalf of a class consisting of all persons who…